London-based HeathTech start-up Reset Health is reportedly considering a £60m listing on the London Stock Exchange.
The company provides medically supervised personalised programmes for reversing type 2 diabetes and obesity, delivered via its custom-made mobile app.
The company can prescribe weight loss jabs such as Wegovy and Ozempic and claims its platform is used by roughly 500,000 people. Clients currently include some NHS trusts and Transport for London.
According to sources reported by The Times, the listing on the junior AIM exchange would look to raise £15m at a valuation of £60m.
Advisors from stockbroker Shore Capital have reportedly been onboarded to advise on the listing.
The news comes after low-cost computer manufacturer Raspberry Pi recorded one of the largest tech IPO in the recent history of the LSE earlier this month.
The round raised £166m for Raspberry Pi at a valuation of £541.6m.
Recent Stories